查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714628

基因組學市場（按產品、技術、類型、應用和最終用戶分類）—2025 年至 2030 年全球預測

Genomics Market by Offering, Technology, Type, Applications, End Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計基因組學市場規模在 2024 年將達到 522.2 億美元，到 2025 年將以 9.78% 的複合年成長率成長至 571.5 億美元，到 2030 年將達到 914.5 億美元。

主要市場統計數據
基準年2024年 522.2億美元
預計年份：2025年 571.5億美元
預測年份 2030 914.5億美元
複合年成長率（%） 9.78%

近年來，基因組學產業經歷了重大變革，推動力來自突破性的技術進步以及對健康和疾病遺傳機制的深入了解。創新方法和新設備的快速整合不僅重新定義了研究範式，也重新定義了臨床應用。該報告對基因組學生態系統進行了深入的概述，詳細介紹了市場動態、細分、區域影響以及在該領域樹立新標竿的主要企業。

研究和商業性利益之間的持續相互作用正在加速發現的步伐。產業相關人員發現自己正處於傳統技術和根本性創新的十字路口，這些創新正在為個人化醫療、作物開發和藥物發現鋪平新的道路。基因組研究的進步有助於改善診斷和治療方法，最終改變患者照護並擴大商業機會。隨著研究機構、醫院、製藥和相關企業整合這些進步，這些變革性創新的影響變得越來越明顯。

此外，市場力量和消費者需求之間的相互作用正在刺激對技術和基礎設施的投資。透過利用尖端定序技術和先進的生物資訊學，各組織正在為更精確、更有效的治療鋪平道路。科學突破與策略舉措的融合預示著快速發展，有望帶來顯著成長。下面，我們概述了這一行業轉變的關鍵方面、對細分的詳細見解以及提供全球基因組趨勢細緻入微的觀點的區域差異。

影響基因體學的變革

基因組學市場最近的轉型變化反映了技術突破、不斷變化的監管環境以及相關人員優先事項的變化。自動化、小型化和整合數據分析的進步重塑了實驗室工作流程和業務效率。定序技術和儀器的新發展實現了以前難以想像的精度和可擴展性水平。

下一代定序平台、數位 PCR 的增強以及不斷擴展的連接複用能力等技術創新共同促成了一種速度、準確性和成本效益不可妥協的範式。同時，我們也對研發進行了投資，以繼續推動生物資訊學和濕實驗室流程的整合。由於樣品製備的改進和分析方法的複雜化，實驗室現在可以非常清晰地揭示複雜的基因突變和表觀遺傳修飾。

此外，不斷發展的監管政策和加強的公私合作在簡化產品開發和加速臨床測試方面發揮著至關重要的作用。這些合作帶來了更多的資金籌措、策略夥伴關係以及相關人員之間的共用願景：基因組學的未來在於創新主導、以患者為中心的解決方案。人工智慧和機器學習的整合以處理龐大的資料集也正在成為改善診斷和開發標靶治療的關鍵驅動力。

總的來說，這些變革性的變化正在推動基因組學產業進入多方面研究與實際應用整合的新領域。技術創新的步伐不斷加快，預示著基因組學的科學和商業將重新定義美好的未來。

基因組學市場的詳細細分見解

基因組學市場的細分分析提供了對不同產品、技術、分析類型、應用和用戶細分的多層次理解。市場綜合研究根據產品、技術、類型、應用和最終用戶進行細分。例如，在產品類別中，市場細分為消耗品、設備和服務。耗材進一步分為套件、檢測試劑和試劑，而設備則分為分析儀和定序儀。這種結構不僅可以實現明確的產品差異化，還可以突顯市場內不同的收益來源。

在技​​術細分方面，重點轉向基因編輯、微陣列、PCR和定序技術的演化。基因編輯技術已針對 CRISPR/Cas9、TALEN 和鋅指核酸酶進行了評估，微陣列技術已通過研究細胞微陣列、DNA 微陣列和蛋白質微陣列得到改進，PCR 技術已細分為數字 PCR、終點 PCR 和即時PCR，定序技術已經過嚴格的分析，涵蓋下一代、桑格和第三代定序方法。這種差異化有助於產業領導者識別成長領域、潛在投資目標和研究趨勢。

根據基因組分析類型，另一種細分包括表觀基因、功能基因組學、藥物基因組學和結構基因組學。這種分類對於使市場產品與特定的科學和臨床目標保持一致、最佳化研究重點和資源分配至關重要。此外，基於應用的細分涵蓋動物遺傳學、作物開發、診斷、藥物發現和開發、個人化醫療以及研究和開發。每個應用都呈現出獨特的挑戰和機會，為技術進步最有可能帶來顯著成果的細分領域提供了洞察。

最後，最終用戶細分提供了農業相關企業、醫院診所、製藥和生物技術公司以及研究機構的市場部署的詳細視角。農業綜合企業業務部門進一步細分為畜牧公司和種苗公司，突顯了農業遺傳學和作物開發方面的專業要求和獨特的市場動態。這種結構化的細分不僅能更了解當前的市場趨勢，還能使相關人員為各自的業務部門制定專門的策略。

這些細分的見解為策略規劃和投資決策提供了堅實的基礎。每個領域都有其獨特的機會和挑戰，全面的分析可以作為應對日益動態的市場複雜性的藍圖。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球遺傳疾病盛行率不斷上升
      • 精準醫療和個人化照護日益成為趨勢
      • 基因組學在農業和法醫學的應用擴展
    • 限制因素
      • 與測試中使用的遺傳多樣性評估相關的擔憂
    • 機會
      • 整合人工智慧和先進的生物資訊學，實現基因組數據分析的自動化和增強
      • 政府和私人組織增加基因組學研究和開發的資金和津貼
    • 任務
      • 缺乏標準化方法降低了基因組學領域實施的效率
  • 市場區隔分析
    • 提供：提高基因組學分析儀器在診斷和了解遺傳疾病方面的相關性
    • 技術：精準、高效、多功能擴展了 CRISPR/Cas9 的應用範圍
    • 類型：功能基因組學在確定基因組成之間的複雜關係方面的優勢日益增強
    • 應用：擴大基因組學在動物遺傳學的應用，以提高抗病性和活力
    • 最終用戶：種子公司採用新基因組學開發產量作物品種
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

6. 基因組學市場（依產品提供）

  • 介紹
  • 耗材
    • 套件和檢測試劑
    • 試劑
  • 裝置
    • 分析儀
    • 序列器
  • 服務

第7章 基因組學市場（按技術）

  • 介紹
  • 基因編輯技術
    • CRISPR/Cas9
    • TALENs
    • 鋅指核酸酶
  • 微陣列技術
    • 細胞微陣列
    • DNA微陣列
    • 蛋白質微陣列
  • PCR技術
    • 數位PCR
    • 終點PCR
    • 即時PCR
  • 定序技術
    • 下一代定序
    • 桑格定序
    • 第三代定序

第 8 章 基因組學市場（按類型）

  • 介紹
  • 表觀基因
  • 功能基因體學
  • 藥物基因組學
  • 結構基因體學

第9章 基因組學市場（按應用）

  • 介紹
  • 動物遺傳學
  • 作物發育
  • 診斷
  • 藥物研發
  • 個人化醫療
  • 研究與開發

第 10 章 基因組學市場（按最終用戶分類）

  • 介紹
  • 農業業務
    • 畜牧公司
    • 種子公司
  • 醫院和診所
  • 製藥和生物技術公司
  • 研究所

第 11 章：美洲基因體學市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12.亞太基因組學市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲基因體學市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • 10x Genomics, Inc.
  • 23andMe Holding Co.
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Centogene NV
  • EPIC Sciences, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare（Now Cytiva）by Danaher Corporation
  • Gencove, Inc.
  • GenScript BIoTech Corporation
  • Guardant Health, Inc.
  • Helix OpCo, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Merck & Co., Inc.
  • Myriad Genetics Laboratories, Inc.
  • Natera, Inc.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Personalis, Inc.
  • Quest Diagnostics
  • SomaLogic, Inc.
  • Sophia Genetics SA
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
Product Code: MRR-434CCDA04CD1

The Genomics Market was valued at USD 52.22 billion in 2024 and is projected to grow to USD 57.15 billion in 2025, with a CAGR of 9.78%, reaching USD 91.45 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 52.22 billion
Estimated Year [2025] USD 57.15 billion
Forecast Year [2030] USD 91.45 billion
CAGR (%) 9.78%

In recent years, the genomics industry has undergone a significant evolution fueled by groundbreaking technological advancements and a deepening understanding of genetic mechanisms that drive both health and disease. The rapid integration of innovative methodologies and novel instrumentation has redefined not only research paradigms but also clinical applications. This document provides an insightful overview of the genomics ecosystem, detailing market dynamics, segmentation, regional influences, and the leading companies that are setting new benchmarks in the field.

The continuous interplay of research and commercial interests has accelerated the pace of discovery. Industry stakeholders are finding themselves at the crossroads of traditional techniques and radical innovations that open new avenues for personalized medicine, crop development, and drug discovery. The evolution of genomic research has also contributed to the refinement of diagnostics alongside therapeutic advancements, ultimately transforming patient care while expanding the opportunities for commercialization. As research institutions, hospitals, and companies engaged in pharmaceutical and biotechnology integrate these advancements, the impact of such transformative innovations is increasingly visible.

Furthermore, the interplay between market forces and consumer demand has stimulated investments in both technology and infrastructure. By harnessing state-of-the-art sequencing techniques and advanced bioinformatics, organizations have paved the way for more precise and efficient therapies. This landscape, marked by rapid development, promises substantial growth driven by a confluence of scientific breakthroughs and strategic initiatives. The narrative that follows outlines key aspects of these industry shifts, detailed segmentation insights, and the regional variations that provide a nuanced perspective on global genomics trends.

Transformative Changes Impacting Genomics

Recent transformative shifts in the genomics market reflect a convergence of technological breakthroughs, evolving regulatory landscapes, and shifting stakeholder priorities. Advancements in automation, miniaturization, and integrated data analytics have reimagined laboratory workflows and operational efficiencies. New developments in sequencing technologies and instrumentation have enabled a level of precision and scalability that was previously unimaginable.

Technological innovations such as next-generation sequencing platforms, digital PCR enhancements, and extended multiplexing capabilities have collectively contributed to a paradigm where speed, accuracy, and cost-effectiveness are non-negotiable. This is complemented by investments in research and development, which continue to drive the convergence of bioinformatics with wet-lab processes. With improved sample preparations and high-throughput analytical methods, laboratories can now uncover complex genetic variations and epigenetic modifications with remarkable clarity.

Further, evolving regulatory policies and increased collaboration across public and private sectors have played a pivotal role in streamlining product development and expediting clinical trials. Such collaboration has led to enhanced funding, strategic partnerships, and a shared vision among stakeholders that the future of genomics rests on innovation-driven, patient-centric solutions. The integration of artificial intelligence and machine learning to process massive data sets has also emerged as a key factor in refining diagnostics and developing targeted therapies.

Overall, these transformative shifts are pushing the genomics industry into new realms where multidimensional research converges with practical applications. The pace of innovation continues to accelerate, signaling a promising future that redefines both the science and business of genomics.

Detailed Segmentation Insights in Genomics Market

The segmentation analysis of the genomics market provides a multilayered understanding of diverse offerings, technologies, analytical types, applications, and user demographics. A comprehensive study of the market is segmented based on offering, technology, type, applications, and end users. For instance, in the offering category, the market is segmented into consumables, instruments, and service. Within consumables, the analysis further distinguishes between kits and assays and reagents, while instruments are reviewed through the lens of analyzers and sequencers. This structure not only clarifies product differentiation but also highlights distinct revenue streams within the market.

Regarding technological segmentation, the focus shifts to the evolution of gene editing techniques, microarray technology, PCR technology, and sequencing technology. Each of these sub-segments is dissected to reveal further insights: gene editing techniques are evaluated with respect to CRISPR/Cas9, TALENs, and zinc finger nucleases; microarray technology is refined by exploring cellular microarray, DNA microarray, and protein microarray; PCR technology is dissected into digital PCR, end-point PCR, and real-time PCR; sequencing technology undergoes rigorous analysis spanning next-generation, Sanger, and third-generation sequencing methods. Such differentiation assists industry leaders in identifying growth areas, potential investment targets, and research trends.

A separate segmentation based on the type of genomic analysis encompasses epigenomics, functional genomics, pharmacogenomics, and structural genomics. This categorization is critical in aligning market offerings with specific scientific and clinical goals, hence optimizing research focus and resource allocation. Moreover, application-based segmentation spans animal genetics, crop development, diagnostics, drug discovery and development, personalized medicine, and research and development. Each application provides unique challenges and opportunities, giving insight into niches where technological advancement is most likely to yield significant results.

Finally, the segmentation based on end users offers a detailed perspective on market deployment across agribusiness, hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes. The agribusiness segment, further delineated into livestock companies and seed companies, underscores the specialized requirements and unique market dynamics in agricultural genetics and crop development. This structured segmentation not only enriches the understanding of current market trends but also enables stakeholders to tailor strategies specifically to their area of operation.

Taken together, these segmented insights provide a strong foundation for strategic planning and investment decisions. With each segment presenting its own set of opportunities and challenges, the comprehensive analysis serves as a roadmap for navigating the complexities of an increasingly dynamic market.

Based on Offering, market is studied across Consumables, Instruments, and Service. The Consumables is further studied across Kits & Assays and Reagents. The Instruments is further studied across Analyzers and Sequencers.

Based on Technology, market is studied across Gene Editing Technique, Microarray Technology, PCR Technology, and Sequencing Technology. The Gene Editing Technique is further studied across CRISPR/Cas9, TALENs, and Zinc Finger Nucleases. The Microarray Technology is further studied across Cellular Microarray, DNA Microarray, and Protein Microarray. The PCR Technology is further studied across Digital PCR, End-Point PCR, and Real-Time PCR. The Sequencing Technology is further studied across Next-Generation Sequencing, Sanger Sequencing, and Third-Generation Sequencing.

Based on Type, market is studied across Epigenomics, Functional Genomics, Pharmacogenomics, and Structural Genomics.

Based on Applications, market is studied across Animal Genetics, Crop Development, Diagnostics, Drug Discovery & Development, Personalized Medicine, and Research & Development.

Based on End Users, market is studied across Agribusiness, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Institutes. The Agribusiness is further studied across Livestock Companies and Seed Companies.

Regional Market Dynamics in a Global Perspective

Global analysis of the genomics market reveals significant regional variations that underline the international pace of innovation and investment. The dynamics in the Americas are marked by advanced research infrastructure, strong investment in biotechnology, and a robust clinical application environment. In contrast, the landscape in Europe, the Middle East, and Africa exhibits rapid adjustments to technological advancements with rising public-private collaborations. Asia-Pacific, meanwhile, continues to demonstrate impressive growth spearheaded by large-scale government initiatives and rapid industrialization, driving innovation and competitive pricing across the market.

These regional insights highlight that while technological and research advancements serve as universal catalysts, local policy frameworks, funding mechanisms, and market readiness differ greatly. Consequently, each region presents unique investment opportunities and specific challenges tailored to their economic and regulatory contexts.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Driving Genomics Innovation

The competitive landscape is characterized by a plethora of key companies that are at the forefront of innovation in the genomics sector. Innovators such as 10x Genomics, Inc. and 23andMe Holding Co. have pioneered platforms that push the boundaries of what is possible in DNA analysis and personalized health insights. Agilent Technologies, Inc. and BGI Genomics Co., Ltd. continue to set high standards in instrument and consumables development, enabling more efficient and expansive analyses. Companies like Bio-Rad Laboratories, Inc. and Centogene N.V. have furthered the field with innovations in assay development and diagnostic capabilities.

Other industry leaders including EPIC Sciences, Inc. and Eurofins Scientific SE underscore the critical role of comprehensive service solutions in driving market adoption. In addition, global entities such as F. Hoffmann-La Roche Ltd. and GE Healthcare (Now Cytiva) by Danaher Corporation have successfully integrated robust R&D with high-quality manufacturing processes, leading to a consistent track record of product reliability. Organizations like Gencove, Inc. and GenScript Biotech Corporation contribute to high-throughput sequencing and gene synthesis respectively, amplifying the reach of genomic technologies.

Leading innovators such as Guardant Health, Inc. and Helix OpCo, LLC have carved niches in clinical diagnostics and data analytics, while renowned firms including Illumina, Inc., Invitae Corporation, and Merck & Co., Inc. continue to lead in research and innovation fronts. The strategic focus of organizations such as Myriad Genetics Laboratories, Inc., Natera, Inc., and Oxford Nanopore Technologies PLC illustrates the sector's ongoing commitment to pushing technological boundaries. An expanding list of influential companies including Pacific Biosciences of California, Inc., Personalis, Inc., and Quest Diagnostics further cement the competitive spirit within this fast-evolving market. The leadership of SomaLogic, Inc., Sophia Genetics SA, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation rounds out a vibrant ecosystem that is continuously reinventing the ways in which genomics is applied for research, diagnostics, and therapeutic innovation.

The collective force of these companies contributes significantly to setting industry standards, driving forward technological innovations, and fostering partnerships that help overcome traditional industry challenges. Their ongoing investment in research and development, global expansion, and commitment to cutting-edge quality and service methodologies ensure that the genomics sector remains dynamic and poised for future growth.

The report delves into recent significant developments in the Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 23andMe Holding Co., Agilent Technologies, Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Centogene N.V., EPIC Sciences, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GE Healthcare (Now Cytiva) by Danaher Corporation, Gencove, Inc., GenScript Biotech Corporation, Guardant Health, Inc., Helix OpCo, LLC, Illumina, Inc., Invitae Corporation, Merck & Co., Inc., Myriad Genetics Laboratories, Inc., Natera, Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., Quest Diagnostics, SomaLogic, Inc., Sophia Genetics SA, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation. Actionable Strategies for Future Industry Success

For industry leaders seeking to secure competitive advantages in the evolving genomics landscape, it is essential to harness technological innovations and streamline operational processes. Prioritizing investments in advanced sequencing technologies, data analytics, and artificial intelligence integration can offer a leap in research capabilities. Leaders are encouraged to foster strategic collaborations that combine academic research with corporate innovation, thereby expanding access to state-of-the-art laboratory facilities and expertise.

Investing in training programs that keep staff updated with the latest technological trends and regulatory updates will further enhance operational efficiency. Integrating flexible business models that can quickly adapt to market trends is equally vital. Moreover, leveraging comprehensive market intelligence and detailed segmentation insights assists in tailoring solutions to meet specific customer requirements while optimizing resource allocation and scaling operations effectively. These proactive initiatives create a robust foundation that not only drives growth but also nurtures innovation in a competitive marketplace.

Final Thoughts on the Genomics Market Evolution

The genomics market continues to demonstrate resilience and adaptability in an era characterized by rapid technological and scientific advancements. A careful analysis of market drivers, segmentation details, and regional variances reveals an industry committed to innovation and sustainability. With a broad spectrum of offerings that range from consumables to sophisticated technologies, the market is well-positioned for sustained growth.

The interplay of collaborative efforts between research institutions, regulatory authorities, and commercial entities paves the way for a future rich in technological breakthroughs and enhanced healthcare outcomes. The continuous evolution of instruments and the diversification of application areas further attest to the sector's dynamic nature. As companies invest in new technologies and embrace cutting-edge analytical methods, the path forward is illuminated by a strategic blend of scientific curiosity and business acumen.

This analysis serves as a robust platform for industry stakeholders looking to understand evolving trends and adapt their strategies accordingly. The careful dissection of market segmentation and the global perspective provided herein underscore the multifaceted opportunities available to those who are agile, forward-thinking, and committed to the pursuit of excellence in genomics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of genetic disorders globally
      • 5.1.1.2. Growing shift toward precision medicine and personalized therapeutics
      • 5.1.1.3. Expanded application of genomics in agriculture and forensic science
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with assessing genetic diversity used in testings
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of AI and advanced bioinformatics for automating and enhancing genomic data analysis
      • 5.1.3.2. Increased funding and grants for research and development in genomics by governments and private organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardized methodologies reducing efficiency in the genomics field implementation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Higher significance of analyzers in genomics for diagnosing and understanding genetic diseases
    • 5.2.2. Technology: Extending applications of CRISPR/Cas9 owing to precision, efficiency, and versatility
    • 5.2.3. Type: Increasing benefits of functional genomics to determine the complex connection between genetic makeup
    • 5.2.4. Applications: Proliferating adoption of genomics in animal genetics for disease resistance and vitality
    • 5.2.5. End Users: Emerging incorporation of genomics by seed companies to develop high-yield crop varieties
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genomics Market, by Offering

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Kits & Assays
    • 6.2.2. Reagents
  • 6.3. Instruments
    • 6.3.1. Analyzers
    • 6.3.2. Sequencers
  • 6.4. Service

7. Genomics Market, by Technology

  • 7.1. Introduction
  • 7.2. Gene Editing Technique
    • 7.2.1. CRISPR/Cas9
    • 7.2.2. TALENs
    • 7.2.3. Zinc Finger Nucleases
  • 7.3. Microarray Technology
    • 7.3.1. Cellular Microarray
    • 7.3.2. DNA Microarray
    • 7.3.3. Protein Microarray
  • 7.4. PCR Technology
    • 7.4.1. Digital PCR
    • 7.4.2. End-Point PCR
    • 7.4.3. Real-Time PCR
  • 7.5. Sequencing Technology
    • 7.5.1. Next-Generation Sequencing
    • 7.5.2. Sanger Sequencing
    • 7.5.3. Third-Generation Sequencing

8. Genomics Market, by Type

  • 8.1. Introduction
  • 8.2. Epigenomics
  • 8.3. Functional Genomics
  • 8.4. Pharmacogenomics
  • 8.5. Structural Genomics

9. Genomics Market, by Applications

  • 9.1. Introduction
  • 9.2. Animal Genetics
  • 9.3. Crop Development
  • 9.4. Diagnostics
  • 9.5. Drug Discovery & Development
  • 9.6. Personalized Medicine
  • 9.7. Research & Development

10. Genomics Market, by End Users

  • 10.1. Introduction
  • 10.2. Agribusiness
    • 10.2.1. Livestock Companies
    • 10.2.2. Seed Companies
  • 10.3. Hospitals & Clinics
  • 10.4. Pharmaceutical & Biotechnology Companies
  • 10.5. Research Institutes

11. Americas Genomics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Genomics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Genomics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Novo Holdings acquired Benchmark Genetics for strategic growth and innovation
    • 14.3.2. Solis Agrosciences enhances its genomic solutions with the acquisition of Ferris Genomics expertise and platform
    • 14.3.3. Myriad Genetics partners with Ultima Genomics to enhance clinical tests using UG 100 sequencing
    • 14.3.4. Labcorp expands genetic testing capabilities with strategic acquisition of Invitae's advanced assets in oncology and rare diseases
    • 14.3.5. Labcorp and Ultima Genomics partner to develop oncology testing with advanced genomics technologies
    • 14.3.6. Ambry Genetics and PacBio unite to illuminate rare disease origins through sequencing 7,000 genomes
    • 14.3.7. Variantyx accelerates expansion with USD 36 million investment for advanced genomic testing
    • 14.3.8. SOPHiA GENETICS and Strand Life Sciences joined hands to enhance precision medicine
    • 14.3.9. Nucleus Genomics launched the DNA analysis product to increase the accessibility of whole-genome sequencing
    • 14.3.10. Ultima Genomics introduces UG 100 for affordable, accurate sequencing advancements
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Agilent Technologies, Inc.
    • 14.4.2. Thermo Fisher Scientific Inc.
    • 14.4.3. Illumina, Inc.
    • 14.4.4. F. Hoffmann-La Roche AG

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. 23andMe Holding Co.
  • 3. Agilent Technologies, Inc.
  • 4. BGI Genomics Co., Ltd.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Centogene N.V.
  • 7. EPIC Sciences, Inc.
  • 8. Eurofins Scientific SE
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. GE Healthcare (Now Cytiva) by Danaher Corporation
  • 11. Gencove, Inc.
  • 12. GenScript Biotech Corporation
  • 13. Guardant Health, Inc.
  • 14. Helix OpCo, LLC
  • 15. Illumina, Inc.
  • 16. Invitae Corporation
  • 17. Merck & Co., Inc.
  • 18. Myriad Genetics Laboratories, Inc.
  • 19. Natera, Inc.
  • 20. Oxford Nanopore Technologies PLC
  • 21. Pacific Biosciences of California, Inc.
  • 22. Personalis, Inc.
  • 23. Quest Diagnostics
  • 24. SomaLogic, Inc.
  • 25. Sophia Genetics SA
  • 26. Thermo Fisher Scientific Inc.
  • 27. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GENOMICS MARKET MULTI-CURRENCY
  • FIGURE 2. GENOMICS MARKET MULTI-LANGUAGE
  • FIGURE 3. GENOMICS MARKET RESEARCH PROCESS
  • FIGURE 4. GENOMICS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. GENOMICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. GENOMICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GENOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOMICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOMICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOMICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOMICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOMICS MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENOMICS MARKET SIZE, BY TALENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOMICS MARKET SIZE, BY ZINC FINGER NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENOMICS MARKET SIZE, BY CELLULAR MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENOMICS MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENOMICS MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENOMICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENOMICS MARKET SIZE, BY END-POINT PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENOMICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GENOMICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENOMICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GENOMICS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GENOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENOMICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GENOMICS MARKET SIZE, BY STRUCTURAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GENOMICS MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENOMICS MARKET SIZE, BY CROP DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL GENOMICS MARKET SIZE, BY AGRIBUSINESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL GENOMICS MARKET SIZE, BY LIVESTOCK COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL GENOMICS MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 216. MALAYSIA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. PHILIPPINES GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 228. PHILIPPINES GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. SINGAPORE GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. SINGAPORE GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. SINGAPORE GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SINGAPORE GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 239. SINGAPORE GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 240. SINGAPORE GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH KOREA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH KOREA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH KOREA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH KOREA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. TAIWAN GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 258. TAIWAN GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. TAIWAN GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. TAIWAN GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. TAIWAN GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TAIWAN GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 263. TAIWAN GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 264. TAIWAN GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. THAILAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. THAILAND GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 270. THAILAND GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. THAILAND GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. THAILAND GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. THAILAND GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. THAILAND GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 275. THAILAND GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 276. THAILAND GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 279. VIETNAM GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 280. VIETNAM GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. VIETNAM GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 282. VIETNAM GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. VIETNAM GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 284. VIETNAM GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. VIETNAM GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. VIETNAM GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 287. VIETNAM GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 288. VIETNAM GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 302. DENMARK GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 303. DENMARK GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 304. DENMARK GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. DENMARK GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. DENMARK GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 307. DENMARK GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 308. DENMARK GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. DENMARK GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. DENMARK GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. DENMARK GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 312. DENMARK GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 313. DENMARK GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 314. EGYPT GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 315. EGYPT GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 316. EGYPT GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 317. EGYPT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. EGYPT GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 319. EGYPT GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 320. EGYPT GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 321. EGYPT GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 322. EGYPT GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. EGYPT GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 324. EGYPT GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 325. EGYPT GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 326. FINLAND GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 327. FINLAND GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 328. FINLAND GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 329. FINLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 330. FINLAND GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 331. FINLAND GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 332. FINLAND GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 333. FINLAND GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 334. FINLAND GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 335. FINLAND GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 336. FINLAND GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 337. FINLAND GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 338. FRANCE GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 339. FRANCE GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 340. FRANCE GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 341. FRANCE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. FRANCE GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 343. FRANCE GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 344. FRANCE GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 345. FRANCE GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 346. FRANCE GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 347. FRANCE GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 348. FRANCE GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 349. FRANCE GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 350. GERMANY GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 351. GERMANY GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 352. GERMANY GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 353. GERMANY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 354. GERMANY GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 355. GERMANY GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 356. GERMANY GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 357. GERMANY GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 358. GERMANY GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 359. GERMANY GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 360. GERMANY GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 361. GERMANY GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 362. ISRAEL GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 363. ISRAEL GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 364. ISRAEL GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 365. ISRAEL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 366. ISRAEL GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 367. ISRAEL GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 368. ISRAEL GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 369. ISRAEL GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 370. ISRAEL GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 371. ISRAEL GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 372. ISRAEL GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 373. ISRAEL GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 374. ITALY GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 375. ITALY GENOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 376. ITALY GENOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 377. ITALY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 378. ITALY GENOMICS MARKET SIZE, BY GENE EDITING TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 379. ITALY GENOMICS MARKET SIZE, BY MICROARRAY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 380. ITALY GENOMICS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 381. ITALY GENOMICS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 382. ITALY GENOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 383. ITALY GENOMICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 384. ITALY GENOMICS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 385. ITALY GENOMICS MARKET SIZE, BY AGRIBUSINESS, 2018-2030 (USD MILLION)
  • TABLE 386. NETHERLANDS GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 387. NETHERLANDS GENOMICS MARKET SIZE, BY CONSUMABLES,